We are live on ! Find out more
FV2GP

Flagship Ventures 2007 General Partner Portfolio holdings

AUM $107M
This Fund
S&P 500
This Quarter Est. Return
-2.95%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$157M
AUM Growth
Cap. Flow
+$146M
Cap. Flow %
93.34%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 58.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGIO icon
1
Agios Pharmaceuticals
AGIO
$2.36B
$92.5M 58.97%
+3,860,738
New +$88M
RCPT
2
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$46.7M 29.8%
+1,611,911
New +$43.2M
TTPH
3
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$15.8M 10.05%
+58,289
New +$13.9M
BGMD
4
DELISTED
BG MEDICINE INC COM STK NEW
BGMD
$1.83M 1.17%
+441,072
New +$1.28M

Similar funds

Flagship Ventures 2007 General Partner's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Flagship Ventures 2007 General Partner, which disclosed 4 positions worth $157M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Agios Pharmaceuticals: 3,860,738 shares worth $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets.

  • Flagship Ventures 2007 General Partner's largest Q4 2013 buy was Agios Pharmaceuticals: 3,860,738 shares worth $92.5M.
  • Flagship Ventures 2007 General Partner's ten largest holdings make up 100% of its $157M portfolio in Q4 2013.
  • Flagship Ventures 2007 General Partner disclosed 4 positions in Q4 2013, its first 13F filing on record.

Based on Flagship Ventures 2007 General Partner's 13F filing for Q4 2013, filed 10 Feb 2014.